Search Results for "Drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug. Results 2511 to 2520 of 2605 total matches.
MiniMed 530G: An Insulin Pump with Low-Glucose Suspend Automation
The Medical Letter on Drugs and Therapeutics • Dec 09, 2013 (Issue 1431)
The Medical Letter®
On Drugs and Therapeutics
Volume 55 (Issue 1431)
December 9, 2013
Published ...
The FDA has approved the MiniMed 530G
(Medtronic), an insulin pump used in combination with
a continuous glucose monitoring sensor (Enlite) that
can stop delivery of insulin when interstitial glucose
reaches a prespecified low level. It is the only sensoraugmented
insulin pump available in the US with this
capability.
Low-Dose Aspirin for Prevention of Preeclampsia
The Medical Letter on Drugs and Therapeutics • Jun 23, 2014 (Issue 1445)
The Medical Letter®
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 145 ...
The American College of Obstetricians and Gynecologists
(ACOG) and the US Preventive Services Task
Force (USPSTF) have recommended that women at
risk for preeclampsia take low-dose aspirin daily after
the first trimester.
In Brief: Midostaurin (Rydapt) for AML and Advanced Systemic Mastocytosis (online only)
The Medical Letter on Drugs and Therapeutics • Aug 14, 2017 (Issue 1527)
with permission by First Databank, Inc. All rights reserved.
©2017. www.fdbhealth.com/policies/drug-pricing ...
The FDA has approved the oral multikinase inhibitor midostaurin (Rydapt – Novartis) for first-line treatment, in addition to standard chemotherapy, of adults with FLT3 (fms-like tyrosine kinase 3) mutation-positive acute myeloid leukemia (AML). About 30% of patients with AML have FLT3 mutations. Midostaurin is also approved as a single agent for treatment of adults with aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm, or mast-cell leukemia. In mastocytosis, midostaurin targets mutant c-KIT, not FLT3.In a randomized, double-blind trial, 717...
In Brief: Dapagliflozin (Farxiga) for Chronic Kidney Disease
The Medical Letter on Drugs and Therapeutics • Jul 26, 2021 (Issue 1629)
. All rights reserved. ©2021. www.fdbhealth.
com/policies/drug-pricing-policy. chronic kidney disease Forxiga ...
The sodium-glucose cotransporter 2 (SGLT2) inhibitor
dapagliflozin (Farxiga – AstraZeneca) has been
approved by the FDA for treatment of adults with
chronic kidney disease (CKD) at risk of progression
(not defined in the label). Dapagliflozin is the first
SGLT2 inhibitor to be approved in the US for treatment
of CKD.
In Brief: Doxycycline for STI Post-Exposure Prophylaxis
The Medical Letter on Drugs and Therapeutics • Jul 22, 2024 (Issue 1707)
of the drug could increase the incidence of nasal colonization with tetracycline-resistant Staphylococcus ...
The CDC has issued a recommendation for use
of a single dose of doxycycline for post-exposure
prophylaxis (PEP) of bacterial sexually transmitted
infections (STIs), specifically syphilis, chlamydia, and
gonorrhea, in men who have sex with men (MSM) and
transgender women (TGW) who had a bacterial STI
within the previous 12 months.
Med Lett Drugs Ther. 2024 Jul 22;66(1707):119-20 doi:10.58347/tml.2024.1707f | Show Introduction Hide Introduction
Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Chronic Weight Management (online only)
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024 (Issue 1708)
pancreatitis and acute gall bladder disease
Drug Eligible Patients Usual Dosage Other Information
GLP-1 ...
View the Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Chronic Weight Management
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-2 doi:10.58347/tml.2024.1708d | Show Introduction Hide Introduction
Sunscreens
The Medical Letter on Drugs and Therapeutics • Jun 23, 2025 (Issue 1731)
: sunscreen drug products for
OTC human use. September 24, 2021. Available at: https://bit.
ly/3SVWg3n.gov ...
Excessive exposure to ultraviolet (UV) radiation can
cause erythema, photoaging, and skin cancer.
Sunscreens are widely used to reduce these risks, but
questions remain about their effectiveness and safety.
In 2021, the FDA proposed a rule that would require
additional safety studies for some sunscreen active
ingredients and mandate better UVA protection in
sunscreen products.
Med Lett Drugs Ther. 2025 Jun 23;67(1731):97-102 doi:10.58347/tml.2025.1731a | Show Introduction Hide Introduction
Dexamethasone Bacterial Meningitis In Children
The Medical Letter on Drugs and Therapeutics • Jan 27, 1989 (Issue 784)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
A recent report in the New England Journal of Medicine suggested that in children with bacterial meningitis, adding the corticosteroid dexamethasone (Decadron; and others) to antibiotic treatment could decrease the incidence of moderate or severe hearing loss.
Balloon Dilatation Of The Prostate
The Medical Letter on Drugs and Therapeutics • Jun 29, 1990 (Issue 821)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
To avoid the morbidity and occasional mortality of transurethral resection or open prostatectomy, some urologists are now using balloon dilatation of the prostatic urethra to treat benign prostatic hypertrophy.
Safe Needles
The Medical Letter on Drugs and Therapeutics • Apr 05, 1991 (Issue 841)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Accidental needlesticks can lead to infection with hepatitis viruses, human immunodeficiency virus, and other blood-borne bacterial, viral, and fungal pathogens (DK Henderson et al, Ann Intern Med, 113:740, 1990). Re-capping used needles is the most frequent cause of needlestick injuries (J Jagger et al, N Engl J Med, 319:284, 1988; MH Becker et al, Am J Infect Control, 18:232, 1990).